CRISPR-SID: Identifying EZH2 as a druggable target for desmoid tumors via in vivo dependency mapping
暂无分享,去创建一个
B. Alman | M. van de Rijn | C. Vanhove | S. Savvides | T. Naert | P. Coucke | K. De Leeneer | K. Vleminckx | M. Al-Jazrawe | D. Creytens | J. Przybyl | T. Van Nieuwenhuysen | S. Demuynck | D. Tulkens